Table S2.
Variables | Category | Progression-free survival analyses
|
|||||
---|---|---|---|---|---|---|---|
Univariate analysis
|
Multivariate analysis
|
||||||
HR | 95% CI | P-value | HR | 95% CI | P-value | ||
Gender | Female/male | 0.25 | 0.09–0.69 | 0.008 | 0.23 | 0.06–0.82 | 0.024 |
Age | <57/≥57 years | 0.39 | 0.17–0.90 | 0.028 | 0.30 | 0.11–0.81 | 0.017 |
Smoking history | No/yes | 0.35 | 0.14–0.91 | 0.031 | 1.69 | 0.45–6.45 | 0.439 |
EGFR status | Exon 19 del/others | 0.31 | 0.12–0.79 | 0.014 | 0.28 | 0.10–0.76 | 0.013 |
IL-6 level* | Lower/higher | 0.57 | 0.25–1.33 | 0.200 | 0.47 | 0.16–1.33 | 0.153 |
Note:
Patients were dichotomized based on the median value (1.7 pg/mL) of posttreatment plasma IL-6.
Abbreviations: CI, confidence interval; EGFR, epidermal growth factor receptor; HR, hazard ratio; IL, interleukin.